Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 2
2019 2
2020 4
2021 9
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E, Dalton AF, Sweet C, Cohn AC, Little DR, Cohen AL, Sandmann D, Payne DC, Gerhart JL, Feldstein LR. Deputy NP, et al. Among authors: moulia dl. N Engl J Med. 2023 Jun 29;388(26):2434-2443. doi: 10.1056/NEJMoa2215201. Epub 2023 May 18. N Engl J Med. 2023. PMID: 37199451
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
Fleming-Dutra KE, Jones JM, Roper LE, Prill MM, Ortega-Sanchez IR, Moulia DL, Wallace M, Godfrey M, Broder KR, Tepper NK, Brooks O, Sánchez PJ, Kotton CN, Mahon BE, Long SS, McMorrow ML. Fleming-Dutra KE, et al. Among authors: moulia dl. MMWR Morb Mortal Wkly Rep. 2023 Oct 13;72(41):1115-1122. doi: 10.15585/mmwr.mm7241e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37824423 Free PMC article.
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
Dalton AF, Diallo AO, Chard AN, Moulia DL, Deputy NP, Fothergill A, Kracalik I, Wegner CW, Markus TM, Pathela P, Still WL, Hawkins S, Mangla AT, Ravi N, Licherdell E, Britton A, Lynfield R, Sutton M, Hansen AP, Betancourt GS, Rowlands JV, Chai SJ, Fisher R, Danza P, Farley M, Zipprich J, Prahl G, Wendel KA, Niccolai L, Castilho JL, Payne DC, Cohn AC, Feldstein LR; CDC Multijurisdictional Mpox Case-Control Study Group; CDC Multijurisdictional Mpox Case Control Study Group. Dalton AF, et al. Among authors: moulia dl. MMWR Morb Mortal Wkly Rep. 2023 May 19;72(20):553-558. doi: 10.15585/mmwr.mm7220a3. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37200229 Free PMC article.
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
Wallace M, Rosenblum HG, Moulia DL, Broder KR, Shimabukuro TT, Taylor CA, Havers FP, Meyer SA, Dooling K, Oliver SE, Hadler SC, Gargano JW. Wallace M, et al. Among authors: moulia dl. Vaccine. 2023 Oct 20;41(44):6456-6467. doi: 10.1016/j.vaccine.2023.07.037. Epub 2023 Jul 30. Vaccine. 2023. PMID: 37527956 Free PMC article. Review.
Development of COVID-19 vaccine policy - United States, 2020-2023.
Oliver SE, Wallace M, Twentyman E, Moulia DL, Godfrey M, Link-Gelles R, Meyer S, Fleming-Dutra KE, Hall E, Wolicki J, MacNeil J, Bell BP, Lee GM, Daley MF, Cohn A, Wharton M. Oliver SE, et al. Among authors: moulia dl. Vaccine. 2023 Dec 28:S0264-410X(23)01466-4. doi: 10.1016/j.vaccine.2023.12.022. Online ahead of print. Vaccine. 2023. PMID: 38158297 Free article.
Emergency Medical Services Provider Experiences of Hospice Care.
Barnette Donnelly C, Armstrong KA, Perkins MM, Moulia D, Quest TE, Yancey AH. Barnette Donnelly C, et al. Among authors: moulia d. Prehosp Emerg Care. 2018 Mar-Apr;22(2):237-243. doi: 10.1080/10903127.2017.1358781. Epub 2017 Dec 4. Prehosp Emerg Care. 2018. PMID: 29199885
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
Wallace M, Moulia D, Blain AE, Ricketts EK, Minhaj FS, Link-Gelles R, Curran KG, Hadler SC, Asif A, Godfrey M, Hall E, Fiore A, Meyer S, Su JR, Weintraub E, Oster ME, Shimabukuro TT, Campos-Outcalt D, Morgan RL, Bell BP, Brooks O, Talbot HK, Lee GM, Daley MF, Oliver SE. Wallace M, et al. Among authors: moulia d. MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):416-421. doi: 10.15585/mmwr.mm7111a4. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35298454 Free PMC article.
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
Fleming-Dutra KE, Wallace M, Moulia DL, Twentyman E, Roper LE, Hall E, Link-Gelles R, Godfrey M, Woodworth KR, Anderson TC, Rubis AB, Shanley E 3rd, Jones JM, Morgan RL, Brooks O, Talbot HK, Lee GM, Bell BP, Daley M, Meyer S, Oliver SE. Fleming-Dutra KE, et al. Among authors: moulia dl. MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):859-868. doi: 10.15585/mmwr.mm7126e2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35771731 Free article.
31 results